ClinicalTrials.Veeva

Menu
C

Collaborative Neuroscience Network | Garden Grove, CA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Lurasidone
Aripiprazole
Dasotraline
Rapastinel
Risperidone
Brexpiprazole
SPD489
BMS-820836
BI 409306
Troriluzole

Parent organization

This site is a part of Collaborative Neuroscience Network

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 134 total trials

Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder

This study will evaluate the efficacy and safety of SPN-821 in adults with major depressive disorder

Begins enrollment in 1 month
Major Depressive Disorder (MDD)
Drug: Placebo
Drug: SPN-821 2400 mg

Efficacy, Safety, and Tolerability of a single administration of COMP360 in participants with treatment-resistant depression (TRD)

Active, not recruiting
Treatment Resistant Depression
Drug: Psilocybin

The purpose of this study is to evaluate the efficacy of troriluzole as adjunctive therapy versus placebo in participants with obsessive compulsive d...

Active, not recruiting
Obsessive-Compulsive Disorder
Drug: Placebo
Drug: Troriluzole

Trial sponsors

Sumitomo Pharma logo
Otsuka logo
Pfizer logo
Boehringer Ingelheim logo
Allergan logo
Indivior logo
Janssen (J&J Innovative Medicine) logo
Roche logo
Bristol-Myers Squibb (BMS) logo
Mass General Brigham logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems